Author/Creator: Harrison, P M - British Library Electronic Legal Deposit Catalogue-Journal Issues and Articles Search Results

Author/Creator Harrison, P M

1. Characteristics of autoimmune hepatitis in patients who are not of European Caucasoid ethnic origin. Issue 5 (1st May 2002)

Authors:: Zolfino, T; Heneghan, M A; Norris, S; Harrison, P M; Portmann, B C; McFarlane, I G
Journal:: Gut
Issue:: Volume 50:Issue 5(2002)
Page Start:: 713
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

2. Current and future management of chronic hepatitis C infection. Issue 990 (18th April 2008)

Authors:: Cross, T J S; Antoniades, C G; Harrison, P M
Journal:: Postgraduate medical journal
Issue:: Volume 84:Issue 990(2008)
Page Start:: 172
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

3. Intravenous acetylcysteine in paracetamol induced fulminant hepatic failure: a prospective controlled trial. Issue 6809 (26th October 1991)

Authors:: Keays, R; Harrison, P M; Wendon, J A; Forbes, A; Gove, C; Alexander, G J; Williams, R
Journal:: BMJ
Issue:: Volume 303:Issue 6809(1991)
Page Start:: 1026
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

4. Management and outcome of pregnancy in autoimmune hepatitis. Issue 1 (1st January 2001)

Authors:: Heneghan, M A; Norris, S M; O'Grady, J G; Harrison, P M; McFarlane, I G
Journal:: Gut
Issue:: Volume 48:Issue 1(2001)
Page Start:: 97
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

5. Myeloma associated amyloidosis presenting as subacute liver failure. Issue 969 (5th July 2006)

Authors:: Cross, T J S; Wendon, J A; Quaglia, A; Salisbury, J R; Heneghan, M A; Harrison, P M
Journal:: Postgraduate medical journal
Issue:: Volume 82:Issue 969(2006)
Page Start:: e13
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

6. P47 De-novo antiviral therapy with nucleos(t)ide analogues in 'real-life' patients with chronic hepatitis B infection: comparison of virological responses between lamivudine + adefovir vs entecavir vs tenofovir therapy. (6th September 2011)

Authors:: Carey, I; Nguyen DorothyJoe, H; Al-Freah, M; Knighton, S; Bruce, M; Suddle, A; Harrison, P M; Agarwal, K
Journal:: Gut
Issue:: Volume 60:(2011)Supplement 2
Page Start:: A22
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

7. P67 Switch to other nucleos(t)ide analogues therapy in chronic hepatitis B cohort on long-term de-novo combination therapy with lamivudine plus adefovir: efficacy and safety. (6th September 2011)

Authors:: Carey, I; Mendes, A; Joshi, D; Bruce, M; Knighton, S; Scalori, A; Hughes, S; Al-Freah, M; Suddle, A; Harrison, P M; Agarwal, K
Journal:: Gut
Issue:: Volume 60:(2011)Supplement 2
Page Start:: A31
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

8. P69 Hepatitis delta RNA level and genotype, and hepatitis B surface antigen titre predict response to PEG-interferon in the treatment of chronic hepatitis delta virus. (16th November 2010)

Authors:: Hughes, S; Carey, I; Shang, D; Horner, M; Bruce, M; Fletcher, I; Cross, T J S; Suddle, A; Agarwal, K; Harrison, P M
Journal:: Gut
Issue:: Volume 59(2010)Supplement 2
Page Start:: A39
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

9. PMO-154 Plasma HBSAG levels decline was similar during subsequent pegylated interferon and nucleos(T)IDE analogues treatment in chronic hepatitis B patients. (28th May 2012)

Authors:: Bruce, M J; Horner, M; Hughes, S; Knighton, S; Joshi, D; Harrison, P M; Agarwal, K; Carey, I
Journal:: Gut
Issue:: Volume 61(2012)Supplement 2
Page Start:: A136
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

10. PMO-157 HBSAG plasma levels decline helps to predict HBEAG loss but is similar in different NUCLEOS(T)IDE analogues regimens. (28th May 2012)

Authors:: Horner, M; Bruce, M J; Knighton, S; Al-Freah, M; Joshi, D; Hughes, S; Suddle, A; Harrison, P M; Agarwal, K; Carey, I
Journal:: Gut
Issue:: Volume 61(2012)Supplement 2
Page Start:: A137
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗